Invention Grant
- Patent Title: Antibodies directed against ICOS for treating graft-versus-host disease
-
Application No.: US14424092Application Date: 2013-09-03
-
Publication No.: US09695247B2Publication Date: 2017-07-04
- Inventor: Gilles Marodon , Daniel Olive , Christine Menetrier-Caux
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , CENTRE LEON BERARD , UNIVERSITÉ D'AIX-MARSEILLE
- Applicant Address: FR Paris FR Lyons FR Marseilles 7
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE LEON BERARD,UNIVERSITÉ D'AIX-MARSEILLE
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE LEON BERARD,UNIVERSITÉ D'AIX-MARSEILLE
- Current Assignee Address: FR Paris FR Lyons FR Marseilles 7
- Agency: Whitham, Curtis & Cook, P.C.
- Priority: EP12306046 20120903
- International Application: PCT/EP2013/068199 WO 20130903
- International Announcement: WO2014/033327 WO 20140306
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K39/00
Abstract:
The invention relates to a specific antibody directed against, for use for treating graft versus host disease.
Public/Granted literature
- US20150239978A1 ANTIBODIES DIRECTED AGAINST ICOS FOR TREATING GRAFT-VERSUS-HOST DISEASE Public/Granted day:2015-08-27
Information query
